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Urocortin 3 overexpression reduces 
ER stress and heat shock response 
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Fahd Al‑Mulla5, Jaakko Tuomilehto4,6, Jehad Abubaker1 & Ali Tiss 1*
The neuropeptide urocortin 3 (UCN3) has a beneficial effect on metabolic disorders, such as obesity, 
diabetes, and cardiovascular disease. It has been reported that UCN3 regulates insulin secretion 
and is dysregulated with increasing severity of obesity and diabetes. However, its function in the 
adipose tissue is unclear. We investigated the overexpression of UCN3 in 3T3‑L1 preadipocytes and 
differentiated adipocytes and its effects on heat shock response, ER stress, inflammatory markers, 
and glucose uptake in the presence of stress‑inducing concentrations of palmitic acid (PA). UCN3 
overexpression significantly downregulated heat shock proteins (HSP60, HSP72 and HSP90) and 
ER stress response markers (GRP78, PERK, ATF6, and IRE1α) and attenuated inflammation (TNFα) 
and apoptosis (CHOP). Moreover, enhanced glucose uptake was observed in both preadipocytes 
and mature adipocytes, which is associated with upregulated phosphorylation of AKT and ERK but 
reduced p‑JNK. Moderate effects of UCN3 overexpression were also observed in the presence of 
400 μM of PA, and macrophage conditioned medium dramatically decreased the UCN3 mRNA levels in 
differentiated 3T3‑L1 cells. In conclusion, the beneficial effects of UCN3 in adipocytes are reflected, at 
least partially, by the improvement in cellular stress response and glucose uptake and attenuation of 
inflammation and apoptosis.
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The corticotropin-releasing factor (CRF) family of neuropeptides and receptors is implicated in the suppression of 
food intake and inflammation as well as in the regulation of energy  balance1. The CRF family consists of ligands, 
CRF, CRF-bp, and urocortins (UCN) 1,2,3, with their receptors, CRHR1 and CRHR2. These neuropeptides are 
expressed in discrete areas of the brain and in the adipose tissue, pancreas, skeletal muscle, and  heart2–4. They 
may play a significant role in various endogenous pathways, including stress  adaptation1. For instance, the 
administration of UCN1 exerts cardioprotective effects on  cardiomyocytes5. The activation of CRFR2 by UCN2 
and UCN3 also activates the Ras and Raf-1 kinase pathways that are critical for  cardioprotection5. UCNs are 
affected by environmental challenges, such as oxidative  stress6,7 and alcohol  consumption8. Interestingly, the 
disruption of CRF2 signaling causes distortion of the endoplasmic reticulum (ER) morphology, accompanied 
by ER stress signaling. Uncontrolled protein ubiquitination affects protein synthesis, secretion, and mistargeting 
under this  condition9.
UCN3 is a recently characterized CRF family member and binds specifically to receptor  CRHR210,11. UCN3 
and CRHR2 are highly expressed in pancreatic β cells, where UCN3 modulates insulin secretion through the 
regulation of somatostatin  secretion4. Moreover, they are co-expressed in the adipose tissue and  adipocytes12, 
suggesting local activity in this tissue. UCN3 is involved in energy  homeostasis13,14, and mice with global UCN3 
overexpression exhibit resistance to metabolic impairment that is related to a high-fat  diet2. The local overex-
pression of UCN3 in the muscle improves local glucose  homeostasis2. Furthermore, impaired UCN3 expression 
is reported in various metabolic syndromes, such as type 2 diabetes (T2D), obesity, polycystic ovary syndrome 
(PCOS), and sleep  apnea4,12,15. Interestingly, UCN3 and CRHR2 are proposed as potential anti-obesity targets 
owing to their co-location with quantitative trait loci for obesity on chromosome 10p15.116. Recently, we reported 
that the plasma UCN3 levels decrease with increased body weight in human subjects without T2D; however, such 
levels increase with concomitant  T2D12. Conversely, the UCN3 levels in the same subjects in the subcutaneous 
adipose tissue (SAT) increase with body weight and decrease with  T2D12. These findings indicate the complex 
and crucial roles of UCN3 as a marker/target for controlling metabolic disease progression.
In obese individuals, the adipose tissue is infiltrated with macrophages and is characterized by chronic meta-
bolic stress and low-grade inflammation, which are reflected in disrupted cellular host defense  mechanisms17. 
In addition, impaired defense mechanism and ER stress response are observed in obesity and  diabetes18. This 
impairment includes also heat shock response (HSR) considered as a second cellular defense response—critical 
for protein refolding, repair, and cellular homeostasis—in individuals with  obesity19 and  diabetes20. Some HSR 
proteins (HSPs) are ubiquitously expressed, whereas others are expressed under stress conditions. HSP27 inhibits 
IKKβ and regulates TNFα-induced NF-κB  activation21. HSP72 activation is protective through the binding and 
repression of JNK  phosphorylation22,23. In our previous work, we investigated the impairment of HSPs regula-
tion in obesity and  T2D24,25. HSR may play a significant role in endoplasmic reticulum quality control and could 
relieve ER stress through various  pathways26. GRP78 protein, a HSP and master regulator for ER stress canonical 
markers, is key to crosstalk between HSR and ER stress  responses27. Three ER resident proteins, protein kinase 
RNA-like endoplasmic reticulum kinase (PERK), activating transcription factor-6 (ATF6), and inositol-requiring 
enzyme-1α (IRE1α) are primarily responsible for sensing ER perturbations caused by physiological changes in 
extracellular  conditions28,29.
We hypothesized that the potential protective role of UCN3 in obesity and diabetes is exercised at least par-
tially by facilitating cellular stress response in the adipose tissue. We overexpressed UCN3 in 3T3-L1 adipocytes 
and treated them with palmitic acid (PA) to induce stress. Then, we investigated the status of HSR and ER stress 
response, glucose uptake, and inflammation.
Results
UCN3 overexpression enhances cellular stress response under palmitic acid stress. To elu-
cidate the potential protective role of UCN3 in metabolic disorders, such as obesity and diabetes, UCN3 was 
overexpressed in 3T3-L1 differentiated adipocytes without and with stress-inducing amounts of PA (400 μM) as 
shown in Figure S1. Overexpression of UCN3 in the absence of PA significantly downregulated the expression 
of heat shock proteins, HSP60, HSP72, HSP90, and GRP78, at the mRNA expression levels (p < 0.05) (Fig. 1). 
Treatment with PA significantly increased (p < 0.01) the mRNA expression levels of these proteins. However, the 
increase of HPS60 and HSP72 (p < 0.05 and p < 0.01, respectively) was attenuated by UCN3 overexpression. We 
then evaluated the effects of UCN3 overexpression at the protein levels via western blotting. Despite the more 
pronounced downregulation of HSP90, GRP78 and HSP72 levels due to this overexpression observed in the 
presence of PA, HSP60 protein levels were not decreased as shown above at mRNA levels (Fig. 2). Moreover, only 
a marginal effect of UCN3 overexpression was noted in the absence of PA in contrast to the significant decrease 
in the mRNA levels of all HSPs shown in Fig. 1.
We further evaluated the impact of UCN3 overexpression on ER stress markers and the apoptotic marker 
CHOP. Interestingly, the CHOP expression levels were significantly downregulated at both the mRNA and pro-
tein levels in the presence and absence of PA (Figs. 2 and 3). UCN3 overexpression significantly downregulated 
the PERK mRNA expression levels in the presence and absence of PA (p < 0.05), although this attenuation was 
observed only in the absence of PA for other ER stress regulators, ATF6 and IRE1α (Fig. 3), and their downstream 
genes eIF2α and XBP1 (data not shown).
UCN3 overexpression increases glucose uptake. We evaluated glucose uptake in 3T3-L1 adipocytes 
in the presence or absence of PA treatment, under insulin-stimulated conditions, to further investigate the posi-
tive effect of UCN3 overexpression. As shown in Fig. 4A, glucose uptake was significantly increased in preadipo-
cytes transfected with UCN3 in comparison with the preadipocytes transfected with PCMV control (p < 0.01). 
This increase in glucose uptake was further enhanced (p < 0.01) after continuing 3T3-L1 cell differentiation up to 
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4 days with ectopic UCN3 overexpression. This enhancement was observed despite a part of the increase being 
caused by differentiation (Fig. 4A). Comparable but lesser effects were observed when UCN3 was overexpressed 
in mature differentiated 3T3-L1 cells (day 8) (p < 0.05, Fig. 4B). Comparable effects of UCN3 overexpression on 
glucose uptake were also observed in basal conditions (without insulin stimulated) as shown in Figure S2.
We then investigated the effect of UCN3 overexpression on insulin signaling effectors to provide a preliminary 
explanation to such effects. We therefore examined the expression and phosphorylation levels of Akt, ERK, and 
JNK proteins via western blotting. UCN3 overexpression significantly increased phosphorylation of both Akt/
S473 and ERK and decreased phosphorylation of JNK under basal conditions of insulin (p < 0.05, Figure S3 and 
5). After insulin stimulation, comparable trends were observed but less pronounced for p-Akt and p-ERK. We 
further assessed the effect of UCN3 overexpression on these markers in the presence of PA, under basal insulin 
conditions. While UCN3 increased the phosphorylation of Akt and ERK in the absence of PA, in its presence, 
however, only p-ERK was significantly increased (p < 0.05, Fig. 5).
Urocortin 3 overexpression decreases inflammation. Low-grade chronic inflammation is a char-
acteristic of adipose tissue in patients with obesity and insulin resistance-resistant  patients30. 3T3-L1 preadi-
pocytes were differentiated in the presence of RAW264.7 macrophage conditioned medium (MaCM) using an 
indirect co-culture method to mimic inflammatory conditions. We evaluated the expression levels of UCN3 and 
HSPs. Under normal conditions, UCN3 mRNA expression was increased with differentiation, as we previously 
 reported12. However, a clear downregulation of the UCN3 mRNA levels (p < 0.05) was observed in the presence 
of MaCM (Fig. 6). Under MaCM stress-inducing conditions, the expression levels of HSP60, HSP72, HSP90, 






















































Figure 1.  Expression profile of HSPs in 3T3-L1 adipocytes under PA treatment. mRNA expression levels of 
HSP60, HSP72, HSP90, and GRP78 were measured by quantitative real-time PCR in 3T3-L1 adipocytes in the 
absence and presence of PA (400 µM) overnight. GAPDH was used as an internal control for normalization 
and data are presented as fold changes under each condition compared with adipocytes transfected with PCMV 
from independent experiments (n = 4). *p < 0.05; **p < 0.01.
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and IRE1α, was also observed; however, it did not reach statistical significance (Fig. 7). The effect was more pro-
nounced for the apoptotic marker, CHOP (p < 0.05).
These observations prompted us to investigate the effect of UCN3 overexpression on representative inflam-
matory markers. Overexpression significantly decreased the expression levels of TNFα mRNA in the absence 
and presence of PA (Figure S6). Moreover, a similar decrease in the IL6 mRNA expression levels was observed 
in the presence of PA, but the opposite effect was observed in the absence of PA (Figure S6).
Urocortin 3 is negatively associated with circulating HSP60 and GRP78 in adult humans with 
obesity. In a previous study, we reported a decrease in UCN3 levels in the plasma of subjects that are over-
weight and subjects with obesity compared with normal-weight  individuals12. Based on the effects of UCN3 
overexpression on HSPs and ER markers in adipocytes, and the opposite trends in the UCN3 and HSPs levels in 
MaCM, we revisited our previous data and conducted correlation analyses to evaluate the circulating levels of 
UCN3, HSP60, and GRP78. A description of the population study, the methods used, and the results are detailed 
in previous  reports12,24,31. Interestingly, significant negative correlations between the UCN3 levels and the HSP60 
and GRP78 levels were observed (R =  − 0.384, p = 0.001, and R =  − 0.285, p = 0.006, respectively) using data from 
144 non-diabetic humans with various body mass indices (Figure S7). However, no correlation was observed in 
the analysis of similar data for a subgroup with diabetes (data not shown).
Discussion
UCN3 exhibits a possible beneficial activity for metabolic disorders, such as obesity and diabetes. Moreover, 
it is dysregulated with increasing severity in patients with obesity and  diabetes12. However, its function in the 
adipose tissue is unclear. In a previous  study12, we reported the status of UCN3 in the plasma and adipose tissue 
of subjects with overweight or obesity. In the present study, we demonstrate that UCN3 overexpression in 3T3-
















































































































Figure 2.  Expression levels of HSPs and CHOP in 3T3-L1 adipocytes under PA treatment. The protein 
levels were measured by Western Blot using 3T3-L1 adipocytes treated overnight with PA (400 µM). Gels are 
representative of at least three independent experiments. Quantitative data are normalized to internal GAPDH 
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events are associated with improved glucose uptake in both pre-mature and mature adipocytes. Comparable 
effects are also observed in the presence of PA as a metabolic stressor. We found negative correlations between the 
circulating levels of UCN3 and HSP60 as well as GRP78 in human plasma and in MaCM differentiated 3T3-L1 
adipocytes. To the best of our knowledge, this report is the first to elucidate the mechanisms for the protective 
effect of UCN3 overexpression in adipocytes accompanied by enhanced glucose uptake and insulin signaling 
through the upregulation of phosphorylation of Akt and ERK but downregulation of p-JNK.
UCN3 and its receptor CRHR2 are expressed in various tissues, including the pancreatic β-cells and adipose 
 tissue3,4. Co-expression of UCNs and their receptors within the same tissues may indicate a physiologic paracrine 
function. In support of this, UCN3 overexpression improves glucose uptake and insulin signaling in the skeletal 
muscle through an autocrine/paracrine mechanism with upregulated GLUT1,4 and  AMPK2. Moreover, UCN3 
gene transfer exerts beneficial effects on weight loss, reduced liver fat, and enhanced glucose  control32. We also 
reported previously that the levels of UCN3 in SAT were increased in obesity but attenuated in diabetes, which 
is consistent with the low UCN3 expression in the β-cells obtained from subjects with  diabetes12.
Interestingly, our results demonstrated increased glucose uptake both by preadipocytes and mature adipo-
cytes when UCN3 is overexpressed. In agreement with these results, UCN3 + transgenic mice are likely pro-
tected from metabolic challenges by a favorable phenotype that counters obesity and hyperglycemia, possibly 
via augmented glucose metabolism and uptake as well as fatty acid  metabolism33. Furthermore, UCN3 KO mice 
exhibited improved insulin sensitivity and metabolic resiliency under high-fat feeding, whereas aged UCN3 KO 
mice exhibited better glucose homeostasis compared with WT  mice34,35. By disturbing the UCN3 levels, both 
UCN3 overexpression and UCN3 KO mice exhibited metabolic protection. Moreover, muscle CRFR2 stimula-
tion improved muscle mass and glucose  homeostasis33,36. Hence, the improved metabolic status observed is at 
least partially due to UCN3 overexpression and action in the periphery.
Conversely, HSPs are key players in mitigating cellular and tissue stress to maintain cellular homeostasis 
through crosstalk with ER stress and inflammation  regulators17,19. In humans with diabetes, the levels of HSPs, 
in particular HSP72,  decreased20, but in subjects with obesity without diabetes, we recently observed increased 
levels in both the adipose tissue and  blood24,25,31. These contrasting findings in two metabolic disorders, which are 
known to be associated with insulin resistance, indicate that HSR might resolve moderate metabolic stress related 
to obesity, but not more severe stress observed in diabetes. Our current results further support this hypothesis 





































































Figure 3.  Expression profile of ER stress markers in 3T3-L1 adipocytes under PA treatment. mRNA expression 
levels of PERK, ATF6, IRE1α, and CHOP were measured by quantitative real-time PCR in 3T3-L1 adipocytes in 
the absence and presence of PA (400 µM) overnight. GAPDH was used as an internal control for normalization 
and data are presented as fold changes under each condition compared with adipocytes transfected with PCMV 
from independent experiments (n = 4). *p < 0.05; **p < 0.01.
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concentrations of PA increased HSR, ER stress response markers, and apoptosis marker, CHOP, as expected. 
However, UCN3 overexpression before PA treatment decreased the level of HSPs in adipocytes and likely elimi-
nated the requirement for the activation of these defense mechanisms. Of note, the variations in the HSP gene 
and protein expression levels upon the UCN3 overexpression were not always correlating. This could be due to 
multiple posttranslational modifications or change in the cell environment modulating its protein levels under 
metabolic stress conditions. The complex crosstalk and back-regulation between the HSR, ER stress markers, 
and inflammation might also impact the need for translation of HSPs. This may particularly affect GRP78 and 
HSP60 involved in the UPR system and inflammatory reaction, respectively.
Notably, UCN3 overexpression had a limited impact on ER stress markers in the presence of PA compared 
with its absence. Similar trends are also observed in phosphorylation of Akt, JNK, and ERK, which are all 
involved in insulin signaling. This may be explained by an overwhelming exposure to stress that exceeds the cel-
lular response capacity of these sensitive and canonical regulators and thus impairs their functions in metabolic 
diseases, such as diabetes. We and others previously reported that the expression levels of ER stress master regu-
lator GRP78 are differentially dysregulated in obesity and  diabetes24,25,31. UCN3 may mitigate metabolic events 
through enhanced cellular stress defense mechanisms. The clear downregulation in the CHOP levels observed 
in the absence and presence of PA associated with UCN3 overexpression is consistent with the previous studies.
Numerous metabolic disorders are also associated with inflammation, mitochondrial dysfunction, and 
 apoptosis37. It has been reported that UCNs exert anti-inflammatory activity via the PI3K/Akt and GSK 
 pathways38. Further, the cardioprotective effect of UCN1, UCN2, and UCN3 is suggested to involve the MAPK 
 pathway40–41. We observed UCN3 anti-inflammatory activity in the presence of PA, as reflected in the down-
regulation of the TNFα and IL6 expression levels. However, the increase in IL6 expression due to UCN3 over-
expression in the absence of PA is unexpected. Aside from its established pro-inflammatory role, IL6 cytokine 
also exhibits numerous non-inflammatory physiological actions, including increased glucose disposal, lipolysis, 
glucose and increased energy  expenditure42. When activation is prolonged, IL6 becomes pathogenic; however, 
short-term IL6 signaling exerts cardioprotective effects on myocardial infarction in response to tissue  damage43. 
Thus, the attenuation of some cellular defense systems, such as HSR, due to UCN3 overexpression may be com-
pensated by the increased levels of IL6 to fulfill some physiological roles.
We also observed a significant negative correlation between the UCN3 level and HSP60 and GRP78 levels 
in human plasma. However, this association is not observed in subjects with diabetes. Moreover, in a previous 
 report12, we observed an association between UCN3 and the regulated on activation, normal T cell expressed 
and secreted chemokine (RANTES) in subjects with diabetes, which was not present in the non-diabetic patients. 





































Figure 4.  Glucose uptake in 3T3-L1 preadipocyte and differentiated adipocyte cells. Glucose uptake 
experiments were measured as detailed in material and methods. Data are presented as percentage increase 
of glucose uptake under each condition compared with cells transfected with PCMV in absence of PA from 
independent experiments (n = 7 to 9). **p < 0.01.
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Consistent with these findings, we report that indirect co-culture with MaCM induces a decrease in UCN3 
expression and an increase in ER stress, HSPs, and CHOP levels. Conditioned medium represents low-grade 
inflammation in the adipose tissue, as observed in obesity. Hence, the local microenvironment may affect the 
expression levels of UCN3, and UCN3 may participate in adaptive responses to maintain homeostasis. However, 
with chronic stress, this effect is attenuated.
Our findings are in agreement with those of previous studies, which demonstrate that increased UCN3 
levels may exert protective effects against moderate or transient metabolic insults. Still, the physiological role 
and mechanism of action of UCN3 are complex, and its beneficial effects require signal integration among cell 








































































Figure 5.  Expression and phosphorylation levels of Akt, JNK and ERK proteins in 3T3-L1 adipocytes 
under PA treatment and basal insulin conditions. The protein levels were measured by Western blot using 
3T3-L1 adipocytes treated overnight with PA (400 µM). Gels are representative of at least three independent 
experiments. Quantitative data are normalized to internal GAPDH and presented as fold changes under each 
condition compared with adipocytes transfected with PCMV (n = 5). *p < 0.05.
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understanding of the molecular mechanisms that regulate UCN3 expression and action is expected to provide 
critical insight into its role in the pathophysiology of various metabolic disorders.
To the best of our knowledge, the present study is the first to report enhanced heat shock and ER stress 
responses and glucose uptake with UCN3 overexpression in adipocytes under metabolic stress. In vitro work 
































































Figure 6.  Expression levels of UCN3 and HSPs during the differentiation of 3T3-L1 preadipocytes and their 
treatment with a macrophage culture medium (MaCM). mRNA expression levels of UCN3, HSP90, GRP78, 
CHOP, HSP72, and HSP60 were measured by quantitative real-time PCR in 3T3-L1 preadipocytes (d0) and 
adipocytes differentiated for 8 days (d8) with and without MaCM. GAPDH was used as an internal control for 
normalization and data are presented as fold changes in differentiated adipocytes compared with preadipocytes 








































3T3 diff. + MaCM
Figure 7.  Expression levels of ER stress and apoptotic markers during the differentiation of 3T3-L1 
preadipocytes and their treatment with a macrophage culture medium (MaCM). mRNA expression levels 
of PERK, ATF6, and IRE1α were measured by quantitative real-time PCR in 3T3-L1 preadipocytes (d0) and 
adipocytes differentiated for 8 days (d8) with and without MaCM. GAPDH was used as an internal control for 
normalization and data are presented as fold changes in differentiated adipocytes compared with preadipocytes 
from independent experiments (n = 4). *p < 0.05.
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limitations, such as lack of knockdown experiments for the validation and assessment of the status of the CRHR2 
receptor in used cells. A detailed characterization of insulin signaling pathways under metabolic stress follow-
ing UCN3 overexpression is planned, and the results are expected to further elucidate the action of UCN3 on 
adipocytes in the context of obesity and diabetes.
Methods
Cell culture, transfection, and treatment. Mouse preadipocyte (3T3-L1) and macrophage (RAW264.7) 
cells were purchased from the American Type Culture Collection (VA, USA) and then cultured as previously 
 described12,44. Briefly, 3T3-L1 cells were normally differentiated into mature adipocytes until day 8, and in indi-
rect co-culture, 3T3-L1 cell differentiation was induced in conditioned media from RAW264.7 cells. Oil red O 
staining of lipid droplets was used to monitor cell differentiation as previously  described12.
Human UCN3 gene cloned in pCMV6 vector tagged with Myc-DDK (OriGene, Rockville, MD, USA) was 
used for transfection. Myc-DDK tagged pCMV6 vector without UCN3 (OriGene, Rockville, MD, USA) was 
used as a control. 3T3-L1 adipocytes were transfected via electroporation using the Cell Line Nucleofector Kit 
(Lonza, Basel, Switzerland) according to the manufacturer’s instructions. Briefly, 2 ×  106 cells were electroporated 
with 2 μg of plasmid using Nucleofector program, A-033. About 24 h after transfection, the cells were treated 
with 400 µm of PA (Sigma-Aldrich, St. Louis, MA, USA) in low glucose (1 g/l) and 1% (w/v) serum medium for 
24 h with and without insulin (20 nM for 10 min). PA was prepared in 10% (w/v) fatty acid free bovine serum 
albumin (BSA). The cells were then processed for RNA and protein analyses or plated for glucose uptake assay.
Glucose (2‑NBDG) uptake assay. Adipocytes were placed into a 96-well plate for glucose uptake assay 
using a cell-based assay kit (#600470, Cayman Chemical, Ann Arbor, MI, USA) according to the manufac-
turer’s instructions. The culture medium was replaced with 100 µL of glucose-free medium 24 h after plating to 
starve cells. After 1 h of starvation, the medium was replaced with fluorescently labeled deoxy-d-glucose analog 
(2-NBDG) (150 µg/mL) and with and without insulin (0.1 µm) at 37 °C for 1 h. The cells were then washed with 
the buffer provided, and fluorescence was measured using a Synergy H4 plate reader (BioTek, Winooski, VT, 
USA) at 485/535 nm. Glucose uptake experiments were conducted on both preadipocytes and differentiated 
adipocytes transfected with UCN3 and pCMV6 plasmid. Experiments and measurements were also conducted 
on transfected preadipocytes differentiated until day 3.
Quantitative real‑time PCR. TRIzol reagent was used for total RNA extraction according to the manu-
facturer’s instructions. Isolated RNA was quantified using an Epoch spectrophotometer (BioTek, Winooski, VT, 
USA) prior to reverse transcription using a High-Capacity cDNA Reverse Transcription Kit (Applied Biosys-
tems, Foster City, CA, USA). cDNA was then amplified with TaqMan gene expression assay or custom primers 
(Table S1) and normalized to glyceraldehyde 3-phosphate dehydrogenase (GAPDH) using Applied Biosystem 
7500. In the gene expression quantitation, the ΔΔCT method was used and results were reported as fold change.
Western blot analysis. Whole protein extracts from cells were prepared in RIPA buffer (50 mM Tris–HCl, 
pH 7.5, 150 mM NaCl, 1% (w/v) Triton X-100, 1 mM EDTA, 0.5% sodium deoxycholate, and 0.1% (w/v) SDS). 
Protein concentrations were determined using the Bradford method and normalized to β-globulin. Samples 
(20 µg) were prepared in loading buffer containing β-mercaptoethanol and resolved on 10% (w/v) SDS-PAGE 
gels. Then, proteins were transferred onto PVDF membranes (100 V for 75 min) and blocked for 2 h at room 
temperature (RT) using 5% (w/v) nonfat dried milk in Tris-buffered saline containing 0.05% Tween-20. Mem-
branes were probed with the primary antibodies at 4 °C overnight [anti-UCN3 (bs-2786R, Bioss Antibodies Inc., 
MA, USA), anti-HSP90 (ADI-SPA-830-F, Enzo, Farmingdale, NY, USA), anti-HSP72 (ADI-SPA-810-F, Enzo, 
Farmingdale, NY, USA), anti-HSP60 (ADI-SPA-805-F, Enzo, Farmingdale, NY, USA), anti-GRP78 (ab32618, 
Abcam), anti-CHOP (2895S, Cell Signaling Technology, Danvers, MA, USA), p-AKT/AKT, p-JNK/JNK, p-ERK/
ERK (9271, 9272, 4668s, CST 9252L, 9101, and 9102, respectively; Cell signaling, Danvers, MA, USA), GLUT-1 
(cs-129395,cell signaling), GLUT-4 (cs-2231 s, cell signaling) and anti-GAPDH (ab2302, Millipore, Temecula, 
CA)]. Membranes were then washed and incubated with rabbit horseradish peroxidase (HRP)-conjugated sec-
ondary antibody (1:10,000 dilution) for 2 h at RT. Detection was performed using super sensitivity West Femto 
ECL reagent (Thermo Scientific, Waltham, MA, USA), protein bands were visualized by chemiluminescence, 
gel images were captured using the VersaDoc 5000 system (Bio-Rad, Hercules, CA, USA), and band intensities 
were measured using the Quantity One software (Bio-Rad, Hercules, CA, USA). GAPDH was used as an internal 
control for protein loading.
Study population and Blood biochemistry analysis (previously detailed  in12,24,31). A total of 144 
non-diabetic normal weight and overweight subjects (n = 37 and 107 resp.) and 98 T2D subjects were recruited 
for our study as previously  reported12. Participants with prior history of major illness, use of supplements or 
medications affecting body composition or bone mass and those who performed any physical exercise within 
last 6 months before enrollment to study were excluded. The physical, clinical and biochemical characteristics 
have been previously reported. All subjects had provided informed written consent approved by ethics commit-
tee of Dasman Diabetes institute, in line with the principles of the Declaration of Helsinki.
Physical-clinical measurements including body weight, systolic and diastolic blood pressure were made. 
Peripheral blood samples were obtained, and plasma was collected to analyze various inflammatory and meta-
bolic markers. Glucose and lipid levels were measured using Siemens Dimension Chemistry Analyzer (Dia-
mond Diagnostics, Holliston, MA, USA). Haemoglobin A1c (HbA1c) levels were determined with the Variant™ 
device (Bio-Rad, Hercules, CA, USA). Levels of plasma UCN3 (#LS-F12902, Lifespan Biosciences, USA), HSP60 
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(ADI-EKS-600, Enzo, PA, USA), and GRP78 (#ADI-900-214, Enzo LifeSciences, Switzerland) were assayed using 
ELISA kits, according to manufacturer’s instructions. Absorbances were measured on H4 Synergy plate reader 
(Biotek, Winooski, VT, USA).
Statistical analysis. Statistical analyses were conducted using the SPSS software v25.0 (IBM SPSS Sta-
tistics for Windows, IBM Corp. Armonk, NY, USA). All descriptive statistics in the study are expressed as 
mean ± standard error and at least 3 repeats were performed for each experimental condition. Nonparametric 
Mann–Whitney U tests were employed to evaluate the differences in the means between pairs of cell conditions. 
Correlations among variables were estimated using Spearman’s correlation coefficient. All p-values < 0.05 were 
considered statistically significant.
Data availability
All generated data and resources are reported in this manuscript and there is no other data to be provided.
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